Radiation for prostate cancer may increase fracture risk
Monday, May 31st, 2010 Posted in prostate cancer risks | No Comments »A recent research suggests that prostate cancer patients who undergo three-dimensional external-beam radiation therapy may be at high risk of breaking their hips, but they can take action to strengthen their bones after treatment. Doctors already know that treatment with androgen-suppression ...
About PSA accuracy in identifying prostate cancer
Sunday, May 30th, 2010 Posted in prostate cancer diagnosis | No Comments »The prostate specific antigen (PSA) test, although considered a prostate-specific test, is not really an absolute definitive test for the cancer. According to statistics, the PSA test is known to be somewhere between 85 and 95 percent accurate in identifying ...
Questions regarding selection of patients for active surveillance at VA medical centers
Friday, May 28th, 2010 Posted in watchful waiting | No Comments »A recent study at University of California-San Diego, reports that patients in the SEARCH database who would theoretically have been eligible for active surveillance (AS) for low-risk prostate cancer were actually at increased risk for recurrence if they were of ...
Sanofi prostate cancer drug shows 28 percent survival
Thursday, May 27th, 2010 Posted in prostate cancer | No Comments »The outcome of a final-stage trial showed that Sanofi-Aventis' cabazitaxel candidate prostate cancer drug combined with prednisone reduced the risk of death by 28 percent compared with another treatment The clinical trial results will be presented at the 2010 American Society ...
Diabetes lowers the risk of prostate cancer
Wednesday, May 26th, 2010 Posted in prostate cancer risks | No Comments »German, Swedish and U.S. researchers reported they found a lower rate of prostate cancer among people with diabetes. However, according to study leader, the researchers could only speculate about the causes. Researchers also found higher risks of several cancers in those with type ...
Does concurrent statin therapy help men who have EBRT for localized disease?
Tuesday, May 25th, 2010 Posted in prostate chemotherapy, radiation therapy | No Comments »A scientific team at Memorial Sloan-Kettering Cancer Center, New York, wanted to investigate the potential impact of statin therapy on biochemical progression-free survival and metastasis-free survival after high-dose radiotherapy for localized prostate cancer. To do this, researchers conducted a retrospective ...
Tasquinimod in treatment of patients with metastatic CRPC
Monday, May 24th, 2010 Posted in hormone therapy | No Comments »Tasquinimod is an orally administered, investigational drug that has previously been shown to have both anti-angiogenic properties and anti-tumor activity in prostate cancer models. Earlier clinical trials of tasquinimod have shown that is well tolerated and that it may delay progression ...
Gene fusion may be behind prostate cancer, not androgen receptors
Sunday, May 23rd, 2010 Posted in prostate cancer | No Comments »A new study at University of Michigan reveals.the main cause of prostate cancer could be the fusion of two genes and the subsequent abnormal prostate cell growth that results when receptors for the hormone androgen get blocked. Researchers suggest the ...
Provenge, another option for prostate cancer patients
Saturday, May 22nd, 2010 Posted in prostate cancer | No Comments »Today a new prostate cancer treatment option, Provenge, was approved by the Food and Drug Administration (FDA). The drug offers hope for men (and their families) to potentially extend and improve the quality of life for those who are suffering ...
Exercise during and after prostate cancer treatment result in a better quality of life
Friday, May 21st, 2010 Posted in prostate cancer | No Comments »According to researchers at Henry Ford Hospital in Detroit, prostate cancer patients who regularly exercise during and after cancer treatment report having a better quality of life and being less fatigued. Exercise is a great alternative to patients combating fatigue and ...